Skip to main content
Yingde Greatchem Chemicals Co., Ltd. logo

Yingde Greatchem Chemicals Co., Ltd. — Investor Relations & Filings

Ticker · 300804 ISIN · CNE100006434 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2026-05-28 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300804

About Yingde Greatchem Chemicals Co., Ltd.

https://www.greatchem.com.cn

Yingde Greatchem Chemicals Co., Ltd. specializes in the research, development, and manufacturing of high-performance specialty materials and fine chemical products. The company’s core portfolio includes UV-curable resins, monomers, and photoinitiators designed for advanced industrial applications. These products are primarily utilized in the formulation of high-end printing inks, electronic materials, protective coatings, and specialized adhesives. The firm maintains a strong focus on technical innovation and quality management, utilizing sophisticated synthesis processes to provide high-purity solutions. Its operations support diverse manufacturing requirements, offering materials that enhance performance characteristics such as durability, adhesion, and curing efficiency across various technical environments.

Recent filings

Filing Released Lang Actions
关于特定股东减持股份的预披露公告
Major Shareholding Notification Classification · 35% confidence The document is a pre‐disclosure announcement of specific shareholders’ planned reduction of their equity stakes in the listed company (“特定股东减持股份的预披露公告”). It does not involve the company issuing or buying back its own shares, nor is it an executive insider transaction or a dividend notice. Instead, it notifies changes in share ownership levels by significant shareholders. This aligns with the definition of Major Shareholding Notification (MRQ).
2026-05-28 Chinese
关于特定股东减持股份计划期限届满暨实施情况的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement by Guangdong Guangkang Biochemical Technology Co., Ltd. on the expiration and implementation of a specific shareholders’ share reduction plan. It details the number of shares sold, methods, dates, and changes in shareholding percentages by major investors. This fits the definition of a Major Shareholding Notification (notification of changes in significant share ownership levels), not a company share buyback, management change, or financial report.
2026-05-25 Chinese
广康生化2025年度股东会法律意见
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter from a law firm on the proper convening, attendance and voting procedures/results of the company’s 2025 Annual General Meeting. It is not the AGM presentation itself, nor the formal voting-results announcement in isolation, nor a financial report. It is a counsel’s attestation/opinion letter and thus falls under the catch‐all “Regulatory Filings” category rather than a specific report type.
2026-05-14 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is an official announcement of the resolutions and detailed vote outcomes from the 2025 Annual General Meeting (shareholders’ meeting) of Guangdong Guangkang Biochemical Technology Co., Ltd. It provides the meeting logistics, lists each proposal, and gives vote tallies (agree, oppose, abstain) including small shareholders’ breakdowns. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-14 Chinese
2025年度募集资金存放、管理与使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from Guangdong Guangkang Biochemical Technology Co., Ltd. regarding the 2025 annual status of the raising, management, and use of funds raised through its initial public offering. It includes extensive financial data on the amount raised, usage, balance, management agreements, investment projects, changes in project scope and location, and cash management activities related to the raised funds. The document references regulatory approvals, audit reports on fund verification, and compliance with securities exchange rules. It is a specialized report focused on the use and management of capital raised by the company, not a general annual report or earnings release. This type of document aligns with a Capital/Financing Update (CAP) as it provides updates on fundraising, capital usage, and related financial management activities. The document length and content confirm it is the report itself, not merely an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2026-04-23 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 85% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the year 2025 for Guangdong Guangkang Biochemical Technology Co., Ltd. It includes specific financial figures related to intercompany and related party balances, interest, repayments, and nature of transactions. The document is relatively short (3051 characters) and does not contain a full financial report or comprehensive financial statements. It is a specific financial disclosure related to related party transactions and fund occupation, which is typically part of regulatory compliance disclosures but does not constitute a full annual or interim report. It is not an announcement of a report but a standalone detailed financial summary. Given the nature and content, it best fits under Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories like Annual Report or Interim Report.
2026-04-23 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.